Empyrean Capital Partners, LP Elanco Animal Health Inc Transaction History

Empyrean Capital Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$19.63 - $26.62 $7.85 Million - $10.6 Million	-400,000 Reduced 27.68%	1,045,167 $20.5 Million
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $9.3 Million - $11.7 Million	318,528 Added 28.27%	1,445,167 $46.1 Million
Q2 2021 Aug 16, 2021	BUY	$28.76 - $35.98 $32.4 Million - $40.5 Million	1,126,639 New	1,126,639 $39.1 Million
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $76.9 Million - $86 Million	-2,471,462 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $71.7 Million - $81.1 Million	2,471,462 New	2,471,462 $79.3 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Empyrean Capital Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Empyrean Capital Partners, LP with notifications on news.